Integrated Advisors Network’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Integrated Advisors Network’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,936	Closed	-$15K	–	711
2022 Q4	$15K	Hold	16,936	–	–	﹤0.01%	624
2022 Q3	$27K	Hold	16,936	–	–	﹤0.01%	634
2022 Q2	$34K	Buy	16,936 +600	+4%	+$1.04K	﹤0.01%	651
2022 Q1	$38K	Buy	16,336 +336	+2%	+$1.05K	﹤0.01%	649
2021 Q4	$74K	Buy	16,000 +3,000	+23%	+$18.6K	﹤0.01%	609
2021 Q3	$99K	Hold	13,000	–	–	0.01%	593
2021 Q2	$126K	Sell	13,000 -4,000	-24%	-$31.9K	0.01%	566
2021 Q1	$141K	Buy	+17,000	New	+$180K	0.01%	523

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Integrated Advisors Network's SRNE Position: Q1 2023 in Review

Integrated Advisors Network sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 16,936 shares — an estimated $15K sold.

Integrated Advisors Network first reported a position in SRNE in Q1 2021 and held it in 8 quarters. The position peaked at $141K in Q1 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Integrated Advisors Network reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Integrated Advisors Network sold 16,936 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $15K.
Integrated Advisors Network first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and held it in 8 quarters.
Integrated Advisors Network's Sorrento Therapeutics, Inc. position peaked at $141K in Q1 2021.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Integrated Advisors Network's 13F filing for Q1 2023, filed 8 May 2023.